Of note, the patient most recently underwent rigid bronchoscopy on [**3-24**] with tumor debulking via cryotherapy.
On arrival to the [**Hospital1 18**] ED, inital VS 100.3 119 103/61 20 95%RA.
He had a CXR that demonstrated possible left base consolidation.
He received vancomycin and 1L IVF, and a CT Trachea per IP.
Past Medical History: PAST ONCOLOGIC HISTORY: Treatment history - [**2131-12-6**] Began RT - [**2131-12-7**] C1D1 Cisplatin/Etoposide similar to SWOG regimen for IIIA/B NSCLC - [**2131-12-28**] Docetaxel 75mg/m2, progression after Cis-Etop - [**2132-1-14**] Completed 5400cGy RT to upper airway .
Fiberoptic nasopharyngolaryngoscopy demonstrating a right true vocal cord paralysis; subsequent CT scan of neck/chest revealed a large paratracheal mass.
-- [**2131-9-24**] underwent rigid bronchoscopy with tumor excision and endobronchial biopsy; pathology revealed poorly-differentiated squamous cell carcinoma.
-- [**2131-11-21**] PET scan showed irregular right posterior tracheal mass with extension into the tracheal lumen.
-- [**2131-11-29**] rigid bronchoscopy with tumor debridement and 20x40 metallic Ultraflex covered stent placement.
EUS [**2131-11-28**] suggested tumor invasion of the esophagus with enlargement of 3 paraesophageal lymph nodes.
-- [**2131-12-21**] repeat bronch with deployment of metallic Ultraflex covered stent [**41**] x 40mm within the existing stent.
-- [**2131-12-28**] Docetaxel 75mg/m2, progression after Cis-Etop -- [**2132-1-14**] Completed 5400cGy RT to upper airway -- [**2132-1-30**] repeat bronch with patent stent and no endobronchial lesions.
-- [**2132-3-3**] CT neck with interval decrease in size of the posterior tracheoesophageal groove mass compared to prior.
Remainder of exam deferred given CMO status.
Pertinent Results: LABS: [**2132-4-27**] 06:26PM   LACTATE-1.7 [**2132-4-27**] 06:28PM   PT-14.4* PTT-23.8 INR(PT)-1.3* [**2132-4-27**] 06:28PM   PLT COUNT-459* [**2132-4-27**] 06:28PM   NEUTS-86.4* LYMPHS-6.7* MONOS-2.0 EOS-4.7* BASOS-0.2 [**2132-4-27**] 06:28PM   WBC-24.4* RBC-2.99* HGB-8.6* HCT-27.0* MCV-90 MCH-28.8 MCHC-31.9 RDW-15.2 [**2132-4-27**] 06:28PM   GLUCOSE-146* UREA N-17 CREAT-0.6 SODIUM-131* POTASSIUM-3.9 CHLORIDE-95* TOTAL CO2-30 ANION GAP-10  REPORTS:  CXR [**2132-4-27**]: FINDINGS: Single AP upright portable view of the chest was obtained.
CT Trachea [**2132-4-27**]: IMPRESSION: 1.
CODE: DNR/DNI, COMFORT CARE ONLY  Medications on Admission: Albuterol nebs prn Baclofen 10 mg po tid prn Benzonatate 100 mg po tid Bupropion ER 150 mg daily Fentaynl 50 mcg/hr patch Q72H Ipratropium nebs prn Lanzoprazole 30 mg daily Lidocaine nebs Lorazepam 0.5-1 mg Q6H prn Megestrol 400 mg/10mL, 10 mL daily Methylphenidate 10 mg po bid Metoclopramide 10 mg po tid prn Morphine 100 mg/5 mL, [**2-11**] mL Q2-3H prn Scopolamine patch Q72H Trazodone 100-200 mg qhs prn APAP prn Bisacodyl PR prn Maalox prn Colace liquid Miralax prn  Discharge Medications: 1. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization [**Month/Day (3) **]: One (1)  Inhalation Q2H (every 2 hours) as needed for shortness of breath or wheezing.
2. ipratropium bromide 0.02 % Solution [**Month/Day (3) **]: One (1)  Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Start at 7 mg. Lockout: 12 doses/hr.
